Ledger.Open graph →
SEC Form D · filed February 26, 2025

Bambusa Therapeutics, Inc

Offering
$88.9M
Sold
$53.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Sean Marett · Mainz, 2MDirectorShanshan Xu · Boston, MAExec · Director · PromoterTeisha Vandekop · Meridian, TXDirectorDerek Dirocco · South San Francisco, CADirectorHelmut Jeggle · Boston, MADirectorGary Tickel · San Marino, CAExec · Director · PromoterShanshan Xu · Boston, MAExec · Director · PromoterHelmut Jeggle · Boston, MADirectorDerek Dirocco · South San Francisco, CADirectorSean Marett · Mainz, 2MDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗